We are thrilled to share that CurQD® has been selected for a groundbreaking clinical trial funded by the Health section of the U.S. Department of Defense (DoD). Led by Mount Sinai Hospital in New York, the study examines an integrative therapeutic approach for individuals with chronic intestinal conditions.
“This approach may not only yield superior results for individuals, as we observe daily in clinical settings, but also addresses the desire to harness nutritional support with plant-based natural compounds to optimize gut health,” said Nir Salomon, Founder and Director of the Integrative Gastroenterology Unit at Sheba Medical Center and Co-founder and Head of R&D at Evinature.
